Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, and Hematopoietic Stem Cell Transplantation.
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma
Neoadjuvant relatlimab and nivolumab in resectable melanoma
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma
Prognostic significance of acral lentiginous histologic type in T1 melanoma
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial
Prognostic Factors of Hepatosplenic T-cell Lymphoma
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
Dual Roles of RNF2 in Melanoma Progression